Kelly J. Kennedy - 21 Dec 2025 Form 4 Insider Report for GoodRx Holdings, Inc. (GDRX)

Reporting relationship: Director
Issuer ticker: GDRX
Reported as of: 21 Dec 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 22 Dec 2025, 16:20:52 UTC
Prior SEC filing: 25 Jun 2025
Next SEC filing: 21 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Gracye Cheng, Attorney-in-Fact for Kelly J. Kennedy

Key filing fact

Kelly J. Kennedy filed Form 4 for GoodRx Holdings, Inc. (GDRX) on 22 Dec 2025.

Key facts

This page summarizes Kelly J. Kennedy's Form 4 filing for GoodRx Holdings, Inc. (GDRX).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 22 Dec 2025, 16:20.

Change

Previous filing in this sequence was filed on 25 Jun 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001545591 Primary reporting owner

Kennedy Kelly J.

Relationship: Director
Address: C/O GOODRX HOLDINGS, INC., 2701 OLYMPIC BOULEVARD, SANTA MONICA
Signature: /s/ Gracye Cheng, Attorney-in-Fact for Kelly J. Kennedy
Signature date: 22 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GDRX transaction

Class A Common Stock

Options Exercise

Transaction value
Shares: +23,149
Change %: +21%
Price
Shares after: 134,211
Date: 21 Dec 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GDRX transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value: $0
Shares: -23,149
Change %: -50%
Price: $0.000000
Shares after: 23,149
Date: 21 Dec 2025
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 23,149
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Footnote F2

The restricted stock unit award vests as to one-third of the shares underlying the award on each of the first three anniversaries of the grant date, beginning on December 21, 2024, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.